Clin-Path Associates and Diagnostics provides an Integrated Breast Carcinoma Surgical Pathology/ Predictive Marker Report — essential for successful patient management. Current ASCO/CAP guidelines are followed:
Her 2 testing by both FISH and image analysis assisted IHC, following ASCO/CAP guidelines, is performed at our local laboratory. Our diagnostic modalities for positive cases include image analysis for ER, PR, and Her2. We consult regularly with surgeons, radiologists and oncologists to provide the most appropriate care. Clin-Path’s breast pathologists are supported by sophisticated technology and expert staff with:
- In-house Histology Laboratory and Immunohistochemistry Department
- In-house Breast Image Analysis: Estrogen, Progesterone and HER2/neu
- In-house Molecular Pathology Laboratory: Her2 Fluorescence in Situ Hybridization (FISH) and Imaging
- Reporting includes photomicrographs of morphology/IHC/FISH